Re (I) [2-Aryl-1H-imidazo[4,5-f][1,10]phenanthroline] tricarbonyl chloride complexes for selective cancer therapy via potential DNA damage mechanism‡

Lavanya Thilak Babu,Utpal Das,Rishav Das,Binoy Kar,Priyankar Paira,Lavanya Thilak Babu
DOI: https://doi.org/10.1039/d3dt04383e
IF: 4
2024-02-29
Dalton Transactions
Abstract:Of late, selective cancer therapy is a great challenge in eradication of cancer with trifling side effects. To amplify the cytoselective approach of the complexes, here we have developed a few Re(I) [2-Aryl-1H-imidazo[4,5-f][1,10]phenanthroline] tricarbonyl chloride complexes, by screening their potency against HeLa and MCF-7 cell lines along with evaluation of toxicity towards normal kidney cell line (HEK-293). On meticulous investigation, complex [ReI(CO)3Cl(Κ2-N,N-(2c)] (3c) has been unveiled as the most potent anticancer entity compared to other analogues. The complex 3c has also shown competency to induce apoptosis of MCF-7 cells through G2/M phase cell-cycle arrest in association with the generation of ample reactive oxygen species (ROS) and eventually leads to DNA intercalation and internucleosomal cleavage. The order of cytotoxicity of these complexes tracked on their lipophilic character and the electron withdrawing halogen substitution at the para position of phenyl ring in imidazophenanthroline ligand.
chemistry, inorganic & nuclear
What problem does this paper attempt to address?